DFE Pharma — full event log

In 2024 SBTi officially approved DFE Pharma's near-term targets: 42% absolute reduction in Scope 1&2 by 2030 vs 2021 base year; 42% Scope 3 reduction (purchased goods, upstream transport, end-of-life); 30.3% Scope 3 FLAG reduction. Recognized as aligned with 1.5°C pathway.

sustainability_report p.34

In 2024 DFE Pharma recalculated Scope 3 emissions for 2021-2024 using more specific data sources. 94% now based on supplier-specific amount-based data (80% from farm-level lactose supplier data), 4% industry averages, 2% financial proxies. GHG emissions ~3% lower than previously reported.

sustainability_report p.14

Data for Scope 1, 2 and 3 emissions for 2021-2023 were recalculated in 2024 after discontinuation of Quantis tool in 2023. Methodology changed from database/spend-based to more granular supplier-specific data.

sustainability_report p.44

DFE Pharma awarded EcoVadis Gold Medal in May 2024, positioning the company in the top 5% of all rated companies worldwide. Previously held Silver Medal in 2023.

sustainability_report p.33

In 2024 all EU sites operated on 100% green electricity. Renewable energy usage nearly doubled (67k→143k GJ) primarily due to biomass boiler commissioning at new MCC plant in Cuddalore, India.

sustainability_report p.13

DFE Pharma aims to achieve zero deforestation across all primary deforestation-linked commodities by December 31, 2025.

sustainability_report p.34

Goal to ensure all packaging materials used in operations are 100% recyclable by 2030, with 25% reduction in plastic use by 2030.

sustainability_report p.15

DFE Pharma launched a Biodiversity Rating process evaluating suppliers on deforestation prevention, biodiversity conservation, and animal health/welfare. 49% of revenue-based supplier volume evaluated; FLAG suppliers prioritized.

sustainability_report p.18

Global analysis on living wage completed in 2024; committed to pay above 'Fair Wage' defined living wage at all 13 global locations.

sustainability_report p.24

In 2024, DFE Pharma's reporting was consolidated into Royal Friesland Campina's framework for CSRD compliance, while broader sustainability reporting continues independently.

sustainability_report p.4

DFE Pharma is aiming to prioritize emissions reduction through direct abatement, rather than using carbon credits. The firm plans to avoid the use of offsets to achieve 2030 reduction targets. Has invested in carbon-credit-sourced renewable energy projects in the interim until sufficient renewable sources are available. No removals (DAC, BECCS, etc.) disclosed.

sustainability_report p.58

In 2024 the car lease policy was updated so every newly ordered vehicle in Germany and the Netherlands is electric. Whole fleet expected to be fully electrified within 4 years.

sustainability_report p.13

SBTi-validated 42% reduction in Scope 3 emissions from purchased goods and services, upstream transportation and distribution, and end-of-life treatment of sold products by 2030 vs 2021 baseline. Non-FLAG Scope 3 represents ~25% of footprint with >90% of 'other' category being end-of-life and transport.

sustainability_report p.14

All EU sites run on 100% green electricity as of 2024. Renewable energy nearly doubled in 2024 (70k→143k GJ, ~51% of total energy) driven by a biomass boiler at the new Cuddalore MCC capacity expansion in India. The old fossil-fuel boiler runs in parallel during transition and will be phased out by end of Q1-2025. Car lease policy was updated so every newly ordered vehicle in Germany and Netherlands is electric; full fleet electrification expected within 4 years.

sustainability_report p.13

In 2025 DFE Pharma will phase out the use of fossil oil at its Cuddalore site, marking a significant step in reducing Scope 1 emissions. Biomass boiler at the new MCC plant replaces the old fossil fuel boiler. All EU sites already on 100% green electricity for Scope 2.

sustainability_report p.13

FLAG emissions constitute 75% of Scope 3 and 74% of total carbon footprint, driven by dairy/lactose raw materials. 80% of Scope 3 calculation comes directly from farm-level data provided by lactose suppliers. SBTi 30.3% Scope 3 FLAG reduction target by 2030 vs 2021. Strategy relies on supplier collaboration to drive sustainable practices and zero-deforestation commitment by end-2025.

sustainability_report p.14

Three-pronged circular packaging strategy: Recycle (100% recyclable packaging by 2030), Reduce (25% plastic reduction by 2030), Reuse (promote re-use across operations). Degree of packaging material separability improved from 77% (2021) to 92% (2024). Comprehensive database built to assess current status; active engagement with contract manufacturers to close data gaps.

sustainability_report p.15